Literature DB >> 22172279

HPV E7 viral oncoprotein disrupts transcriptional regulation of L1Md retrotransposon.

Diego E Montoya-Durango1, Kenneth S Ramos.   

Abstract

Murine L1Md-A5 retrotransposon is a redox-inducible element regulated by Nrf-2/JunD and E2F/Rb-binding sites within its promoter (5'-UTR). Because the human papillomavirus (HPV) oncoprotein E7 interacts with retinoblastoma (pRb) and members of the AP1 family, studies were conducted to examine functional interactions between HPV E7, pRb, and histone deacetylase 2 (HDAC2) in the regulation of L1Md-A5. Using a transient heterologous transcription system we found that HPV E7 alone, or in combination with HDAC2, disrupted pRb-mediated L1MdA-5 transactivation. HPV E7 also ablated the transcriptional response of L1Md-A5 to genotoxic stress, but did not interfere with basal activity. We conclude that HPV E7 associates with proteins involved in the assembly of macromolecular complexes that regulate antioxidant and E2F/Rb sites within L1MdA-5 to regulate biological activity.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22172279      PMCID: PMC3263525          DOI: 10.1016/j.febslet.2011.12.005

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  31 in total

1.  Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase.

Authors:  L Vandel; E Nicolas; O Vaute; R Ferreira; S Ait-Si-Ali; D Trouche
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

2.  Redox regulation of a novel L1Md-A2 retrotransposon in vascular smooth muscle cells.

Authors:  Kim P Lu; Kenneth S Ramos
Journal:  J Biol Chem       Date:  2003-04-24       Impact factor: 5.157

Review 3.  The role of corepressors in transcriptional regulation by nuclear hormone receptors.

Authors:  Martin L Privalsky
Journal:  Annu Rev Physiol       Date:  2004       Impact factor: 19.318

4.  Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest.

Authors:  A Puga; S J Barnes; T P Dalton; C y Chang; E S Knudsen; M A Maier
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

5.  A CCAAT/enhancer-binding protein site within antioxidant/electrophile response element along with CREB-binding protein participate in the negative regulation of rat GST-Ya gene in vascular smooth muscle cells.

Authors:  Y H Chen; K S Ramos
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

6.  DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters.

Authors:  K D Robertson; S Ait-Si-Ali; T Yokochi; P A Wade; P L Jones; A P Wolffe
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

7.  Deletion analysis defines distinct functional domains for protein-protein and nucleic acid interactions in the ORF1 protein of mouse LINE-1.

Authors:  S L Martin; J Li; J A Weisz
Journal:  J Mol Biol       Date:  2000-11-17       Impact factor: 5.469

8.  A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. Linking dioxin signaling to the cell cycle.

Authors:  N L Ge; C J Elferink
Journal:  J Biol Chem       Date:  1998-08-28       Impact factor: 5.157

9.  More active human L1 retrotransposons produce longer insertions.

Authors:  Alexander H Farley; Eline T Luning Prak; Haig H Kazazian
Journal:  Nucleic Acids Res       Date:  2004-01-23       Impact factor: 16.971

10.  A potential role for the nucleolus in L1 retrotransposition.

Authors:  John L Goodier; Eric M Ostertag; Kurt A Engleka; Maria C Seleme; Haig H Kazazian
Journal:  Hum Mol Genet       Date:  2004-03-17       Impact factor: 6.150

View more
  1 in total

1.  LINE-1 silencing by retinoblastoma proteins is effected through the nucleosomal and remodeling deacetylase multiprotein complex.

Authors:  Diego E Montoya-Durango; Kenneth A Ramos; Pasano Bojang; Lorell Ruiz; Irma N Ramos; Kenneth S Ramos
Journal:  BMC Cancer       Date:  2016-01-25       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.